Sanofi Pharmaceuticals, the US unit of the French pharmaceutical andbeauty company Sanofi, has formed two new groups in the USA, health business management and government sales, to target managed care and government sales in the country.
Heading up the health business management unit is Ross Girglani. Rick Schirmer and Byron Wigodner are named national account directors and will assist in the deployment of the Sanofi health business management group.
Dale Walters is named director, government sales. He is supported by Bob McCullough and Mike Sweeting, who are government sales account executives for the east and west regions, respectively.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze